Japan Approval Sought For Sprycel As First-Line Cancer Drug
This article was originally published in PharmAsia News
Japan is the target of a U.S.-based Bristol-Myers Squibb effort to expand the cancer-treatment indications for its Sprycel (dasatinib)
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The German pricing and reimbursement system has been successful in recognizing the value and uniqueness of orphan drugs.
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.